TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 38 filers reported holding TITAN PHARMACEUTICALS INC DE in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q3 2018 | $1,000 | – | 519 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 519 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 519 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 519 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 519 | 0.0% | 0.00% | – |
| Q1 2017 | $2,000 | 0.0% | 519 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -33.3% | 519 | 0.0% | 0.00% | – |
| Q3 2016 | $3,000 | 0.0% | 519 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | +50.0% | 519 | 0.0% | 0.00% | – |
| Q4 2015 | $2,000 | – | 519 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| THOMPSON DAVIS & CO., INC. | 16,184 | $95,000 | 0.17% |
| Acrospire Investment Management LLC | 30,847 | $181,000 | 0.12% |
| Spark Investment Management LLC | 24,000 | $141,000 | 0.01% |
| ACCURATE INVESTMENT SOLUTIONS, INC. | 2,000 | $12,000 | 0.01% |
| Blume Capital Management, Inc. | 2,546 | $15,000 | 0.01% |
| BLUESTEIN R H & CO LLC | 20,000 | $118,000 | 0.01% |
| Virtu KCG Holdings LLC | 42,562 | $250,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $11,000 | 0.00% |
| Integrated Wealth Management | 910 | $5,000 | 0.00% |
| Krilogy Financial LLC | 800 | $5,000 | 0.00% |